Table 5.
Anticoccidial medication | Performance metric | Saline | Isolate 1 | Isolate 2 | Immucox 500 × |
---|---|---|---|---|---|
Nonmedicated | ADG | 53.3a | 34.1c | 34.5c | 40.7b |
FCR | 1.32a | 1.71c | 1.77c | 1.54b | |
LS | 0.1a | 3.6c | 2.8b,c | 1.8b | |
PEF | 239 | 153 | 145 | 178 | |
OPG | 0 | 5 | 5 | 5 | |
Monensin | ADG | 57.0a | 37.4c | 43.6b | 58.8a |
FCR | 1.23a | 1.54b | 1.48b | 1.22a | |
LS | 0.0a | 3.8b | 2.6b | 0.5a | |
PEF | 252 | 170 | 190 | 264 | |
OPG | 1 | 5 | 5 | 3 | |
Salinomycin | ADG | 58.2a | 42.6b | 40.8b | 58.9a |
FCR | 1.22a | 1.48b | 1.50b | 1.23a | |
LS | 0.2a | 3.6b | 4.3b | 1.5a | |
PEF | 267 | 187 | 180 | 268 | |
OPG | 0 | 5 | 4 | 2 | |
Decoquinate | ADG | 57.6a,b | 55.2b | 59.9a | 60.2a |
FCR | 1.25 | 1.20 | 1.25 | 1.24 | |
LS | 0.3 | 0.2 | 0.8 | 0.0 | |
PEF | 253 | 247 | 262 | 257 | |
OPG | 1 | 3 | 2 | 2 | |
Nicarbazin and narasin | ADG | 58.6a | 42.9b | 43.3b | 58.2a |
FCR | 1.26a | 1.56b | 1.49b | 1.23a | |
LS | 0.0a | 5.2c | 3.5b | 0.0a | |
PEF | 257 | 177 | 190 | 260 | |
OPG | 0 | 5 | 4 | 2 | |
Zoalene | ADG | 48.1a | 34.9c | 36.2c | 42.5b |
FCR | 1.35a | 1.82c | 1.64c | 1.53b | |
LS | 0.1a | 3.2b,c | 4.1c | 2.1b | |
PEF | 213 | 143 | 157 | 179 | |
OPG | 0 | 4 | 4 | 5 |
a-cValues within a row with a unique superscript are significantly different at P ≤ 0.05. Statistical analyses were performed at the cage level for ADG and FCR, and at the individual bird level for LS. No statistical analyses were performed for PEF or OPG values.
Average daily gain (ADG), feed conversion ratio (FCR), production efficiency factor (PEF) from the day of challenge to 5 d after challenge. Lesion score (LS) at 5 d after challenge and oocysts per gram (OPG) score at 7 d after challenge.